Related references
Note: Only part of the references are listed.NONHSAG028908.3 sponges miR-34a-5p to promote growth of colorectal cancer via targeting ALDOA
Chuanzhuo Wang et al.
ONCOLOGY REPORTS (2023)
Implications of estrogen and its receptors in colorectal carcinoma
Plabon Kumar Das et al.
CANCER MEDICINE (2023)
The role of circadian clocks in cancer: Mechanisms and clinical implications
Huiwen Liu et al.
GENES & DISEASES (2023)
A rationalized definition of general tumor suppressor microRNAs excludes miR-34a
Sophie Mockly et al.
NUCLEIC ACIDS RESEARCH (2022)
Effect of 17β-estradiol on the daily pattern of ACE2, ADAM17, TMPRSS2 and estradiol receptor transcription in the lungs and colon of male rats
Iveta Herichova et al.
PLOS ONE (2022)
2.4 GHz Electromagnetic Field Influences the Response of the Circadian Oscillator in the Colorectal Cancer Cell Line DLD1 to miR-34a-Mediated Regulation
Sona Olejarova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Period 2 Suppresses the Malignant Cellular Behaviors of Colorectal Cancer Through the Epithelial-Mesenchymal Transformation Process
Yubo Xiong et al.
CANCER CONTROL (2022)
miR-34a induces immunosuppression in colorectal carcinoma through modulating a SIRT1/NF-κB/B7-H3/TNF-α axis
Fanyi Meng et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
Roles of circadian clocks in cancer pathogenesis and treatment
Yool Lee
EXPERIMENTAL AND MOLECULAR MEDICINE (2021)
A promising effect of zerumbone with improved anti-tumor-promoting inflammation activity of miR-34a in colorectal cancer cell lines
Razieh Dehghan et al.
MOLECULAR BIOLOGY REPORTS (2021)
The role of circadian genes in the pathogenesis of colorectal cancer
Saiedeh Razi Soofiyani et al.
GENE (2021)
The comprehensive landscape of miR-34a in cancer research
Sijing Li et al.
CANCER AND METASTASIS REVIEWS (2021)
Post-transcriptional modulators and mediators of the circadian clock
Geo Anna et al.
CHRONOBIOLOGY INTERNATIONAL (2021)
Molecular mechanisms and physiological importance of circadian rhythms
Alina Patke et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
17 beta-Estradiol reduces inflammation and modulates antioxidant enzymes in colonic epithelial cells
Hee Jin Son et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2020)
LncRNA NEAT1 knockdown attenuates autophagy to elevate 5-FU sensitivity in colorectal cancer via targeting miR-34a
Fen Liu et al.
CANCER MEDICINE (2020)
Low circadian clock genes expression in cancers: A meta-analysis of its association with clinicopathological features and prognosis
Jiangguo Zhang et al.
PLOS ONE (2020)
Tumour-suppressive effect of oestrogen receptor β in colorectal cancer patients, colon cancer cells, and a zebrafish model
Geriolda Topi et al.
JOURNAL OF PATHOLOGY (2020)
Sex-dependent least toxic timing of irinotecan combined with chronomodulated chemotherapy for metastatic colorectal cancer: Randomized multicenter EORTC 05011 trial
Pasquale F. Innominato et al.
CANCER MEDICINE (2020)
Targeting estrogen receptors in colorectal cancer
Joyce Wanjiru Maingi et al.
MOLECULAR BIOLOGY REPORTS (2020)
Ubiquitination-mediated degradation of SIRT1 by SMURF2 suppresses CRC cell proliferation and tumorigenesis
Le Yu et al.
ONCOGENE (2020)
MicroRNAs: Diverse Mechanisms of Action and Their Potential Applications as Cancer Epi-Therapeutics
Anna Sadakierska-Chudy
BIOMOLECULES (2020)
Sex-based differences in inflammatory bowel diseases: a review
Sheila D. Rustgi et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2020)
Targeting REV-ERBα for therapeutic purposes: promises and challenges
Shuai Wang et al.
THERANOSTICS (2020)
Comprehensive review of targeted therapy for colorectal cancer
Yuan-Hong Xie et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer
Lu Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
G1/S cell cycle regulators mediate effects of circadian dysregulation on tumor growth and provide targets for timed anticancer treatment
Yool Lee et al.
PLOS BIOLOGY (2019)
Genistein combined with FOLFOX or FOLFOX-Bevacizumab for the treatment of metastatic colorectal cancer: phase I/II pilot study
Sofya Pintova et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
NaNa Keum et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Expression of miR-34a-5p is up-regulated in human colorectal cancer and correlates with survival and clock gene PER2 expression
Kristina Hasakova et al.
PLOS ONE (2019)
Cyclin D1 silencing impairs DNA double strand break repair, sensitizes BRCA1 wildtype ovarian cancer cells to olaparib
Qian Zhong et al.
GYNECOLOGIC ONCOLOGY (2019)
Sex-Dependent Regulation of Estrogen Receptor β in Human Colorectal Cancer Tissue and its Relationship With Clock Genes and VEGF-A Expression
I Herichova et al.
PHYSIOLOGICAL RESEARCH (2019)
Significance of cyclin D1 overexpression in progression and radio-resistance of pediatric ependymomas
Muh-Lii Liang et al.
ONCOTARGET (2018)
Colorectal Cancer Screening for Average-Risk Adults: 2018 Guideline Update From the American Cancer Society
Andrew M. D. Wolf et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Sex-dependent correlation between survival and expression of genes related to the circadian oscillator in patients with colorectal cancer
Kristina Hasakova et al.
CHRONOBIOLOGY INTERNATIONAL (2018)
Effects of Estrogen on the Gastrointestinal Tract
Xubiao Nie et al.
DIGESTIVE DISEASES AND SCIENCES (2018)
The mammalian circadian system: a hierarchical multi-oscillator structure for generating circadian rhythm
Sato Honma
JOURNAL OF PHYSIOLOGICAL SCIENCES (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2018)
Why are there hotspot mutations in the TP53 gene in human cancers?
Evan H. Baugh et al.
CELL DEATH AND DIFFERENTIATION (2018)
The expression of clock genes cry1 and cry2 in human colorectal cancer and tumor adjacent tissues correlates differently dependent on tumor location
K. Hasakova et al.
NEOPLASMA (2018)
Global patterns and trends in colorectal cancer incidence and mortality
Melina Arnold et al.
GUT (2017)
MicroRNA-34a suppresses colorectal cancer metastasis by regulating Notch signaling
Xuemei Zhang et al.
ONCOLOGY LETTERS (2017)
S-adenosylmethionine and methylthioadenosine inhibit cancer metastasis by targeting microRNA 34a/b-methionine adenosyltransferase 2A/2B axis
Maria Lauda Tomasi et al.
ONCOTARGET (2017)
miR-34a overexpression predicts poor prognostic outcome in colorectal adenocarcinoma, independently of clinicopathological factors with established prognostic value
Stamatia-Maria Rapti et al.
CLINICAL BIOCHEMISTRY (2017)
Is there a sex effect in colon cancer? Disease characteristics, management, and outcomes in routine clinical practice
J. S. Quirt et al.
CURRENT ONCOLOGY (2017)
Estrogen receptor beta as target for colorectal cancer prevention
Cecilia Williams et al.
CANCER LETTERS (2016)
Deregulated expression of cryptochrome genes in human colorectal cancer
Gianluigi Mazzoccoli et al.
MOLECULAR CANCER (2016)
Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1
Jin Ye et al.
ONCOLOGY REPORTS (2016)
Disruption of clock gene expression in human colorectal liver metastases
Sander A. Huisman et al.
TUMOR BIOLOGY (2016)
Negative reciprocal regulation between Sirt1 and Per2 modulates the circadian clock and aging
Rui-Hong Wang et al.
SCIENTIFIC REPORTS (2016)
miR-34a inhibits migration and invasion by regulating the SIRT1/p53 pathway in human SW480 cells
Mingguang Lai et al.
MOLECULAR MEDICINE REPORTS (2015)
miRWalk2.0: a comprehensive atlas of microRNA-target interactions
Harsh Dweep et al.
NATURE METHODS (2015)
miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer
J. Gao et al.
ONCOGENE (2015)
Increased MicroRNA-34b and-34c Predominantly Expressed in Stromal Tissues Is Associated with Poor Prognosis in Human Colon Cancer
Yukiharu Hiyoshi et al.
PLOS ONE (2015)
Dysregulation of MicroRNA-34a Expression in Colorectal Cancer Inhibits the Phosphorylation of FAK Via VEGF
Danhua Zhang et al.
DIGESTIVE DISEASES AND SCIENCES (2014)
A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression
Nobuhiro Okada et al.
GENES & DEVELOPMENT (2014)
Induction of the CLOCK Gene by E2-ERα Signaling Promotes the Proliferation of Breast Cancer Cells
Liyun Xiao et al.
PLOS ONE (2014)
Estrogen receptors alpha (ERα) and beta (ERβ): Subtype-selective ligands and clinical potential
Ilaria Paterni et al.
STEROIDS (2014)
MicroRNAs shape circadian hepatic gene expression on a transcriptome-wide scale
Ngoc-Hien Du et al.
ELIFE (2014)
Mir-34: A New Weapon Against Cancer?
Gabriella Misso et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
Cryptochrome 1 Overexpression Correlates with Tumor Progression and Poor Prognosis in Patients with Colorectal Cancer
Hongyan Yu et al.
PLOS ONE (2013)
Role of cyclin polymorphisms in predicting outcome of 5-fluorouracil-based chemotherapy in colorectal cancer: one piece in a complex puzzle
Melissa J. LaBonte et al.
PHARMACOGENOMICS (2013)
The ways and means that fine tune Sirt1 activity
Javier R. Revollo et al.
TRENDS IN BIOCHEMICAL SCIENCES (2013)
p53 regulates Period2 expression and the circadian clock
Takao Miki et al.
NATURE COMMUNICATIONS (2013)
Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis
S. Giacchetti et al.
ANNALS OF ONCOLOGY (2012)
miRNA-34a is associated with docetaxel resistance in human breast cancer cells
L. Kastl et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Identification of an estrogen-regulated circadian mechanism necessary for breast acinar morphogenesis
Stefano Rossetti et al.
CELL CYCLE (2012)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
The quantitative analysis by stem-loop real-time PCR revealed the microRNA-34a, microRNA-155 and microRNA-200c overexpression in human colorectal cancer
Mojin Wang et al.
MEDICAL ONCOLOGY (2012)
Specific and sensitive quantitative RT-PCR of miRNAs with DNA primers
Ingrid Balcells et al.
BMC BIOTECHNOLOGY (2011)
Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells
Yukihiro Akao et al.
CANCER LETTERS (2011)
Clock Gene Expression Levels and Relationship With Clinical and Pathological Features in Colorectal Cancer Patients
G. Mazzoccoli et al.
CHRONOBIOLOGY INTERNATIONAL (2011)
Prognostic significance of differentially expressed miRNAs in esophageal cancer
Yuxin Hu et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
Magali Olivier et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm
Xiaoming Yang et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Tumor Repressive Functions of Estrogen Receptor β in SW480 Colon Cancer Cells
Johan Hartman et al.
CANCER RESEARCH (2009)
Estradiol Alters Cell Growth in Nonmalignant Colonocytes and Reduces the Formation of Preneoplastic Lesions in the Colon
Charles C. Weige et al.
CANCER RESEARCH (2009)
Integration of microRNA miR-122 in hepatic circadian gene expression
David Gatfield et al.
GENES & DEVELOPMENT (2009)
Use of Hormone Replacement Therapy and the Risk of Colorectal Cancer
Gad Rennert et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
An oestrogen-receptor-α-bound human chromatin interactome
Melissa J. Fullwood et al.
NATURE (2009)
Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells
Yasunori Fujita et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest
Fang Sun et al.
FEBS LETTERS (2008)
Sex-specific differences in the expression levels of estrogen receptor subtypes in colorectal cancer
Natascha C. Nuessler et al.
GENDER MEDICINE (2008)
Estrogen receptor β deficiency enhances small intestinal tumorigenesis in ApcMin/+ mice
Veronique Giroux et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Period 2 Mutation Accelerates ApcMin/+ Tumorigenesis
Patricia A. Wood et al.
MOLECULAR CANCER RESEARCH (2008)
MicroRNA-373 induces expression of genes with complementary promoter sequences
Robert F. Place et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
miR-34a repression of SIRT1 regulates apoptosis
Munekazu Yamakuchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The clock gene Per2 links the circadian system to the estrogen receptor
S. Gery et al.
ONCOGENE (2007)
Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells
Hiroshi Tazawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A microRNA component of the p53 tumour suppressor network
Lin He et al.
NATURE (2007)
Circadian variation in expression of G1 phase cyclins D1 and E and cyclin-dependent kinase inhibitors p16 and p21 in human bowel mucosa
John Griniatsos et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines
Y Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Estrogen differentially regulates expression of Per1 and Per2 genes between central and peripheral clocks and between reproductive and nonreproductive tissues in female rats
TJ Nakamura et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
SW480, a p53 double-mutant cell line retains proficiency for some p53 functions
PJ Rochette et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
The orphan receptor Rev-erbα gene is a target of the circadian clock pacemaker
G Triqueneaux et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2004)
The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo
LN Fu et al.
CELL (2002)
Opposing action of estrogen receptors α and β on cyclin D1 gene expression
MM Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
